Clinical Trial Update: Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis [Phase 1, Phase 2]

View source ↗

Summary

This entry describes a Phase 1/Phase 2 clinical trial evaluating XmAb942 in healthy participants and in individuals with ulcerative colitis. The study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• XmAb942

Snippet

Sponsor: Xencor, Inc. | Conditions: Ulcerative Colitis (UC) | Phase 1, Phase 2 | Status: RECRUITING